Structural Investigation of Rimantadine Inhibition of the AM2-BM2 Chimera Channel of Influenza Viruses

Add time:08/09/2019    Source:sciencedirect.com

SummaryThe M2 channel of influenza A is a target of the adamantane family antiviral drugs. Two different drug-binding sites have been reported: one inside the pore, and the other is a lipid-facing pocket. A previous study showed that a chimera of M2 variants from influenza A and B that contains only the pore-binding site is sensitive to amantadine inhibition, suggesting that the primary site of inhibition is inside the pore. To obtain atomic details of channel-drug interaction, we determined the structures of the chimeric channel with and without rimantadine. Inside the channel and near the N-terminal end, methyl groups of Val27 and Ala30 from four subunits form a hydrophobic pocket around the adamantane, and the drug amino group appears to be in polar contact with the backbone oxygen of Ala30. The structures also reveal differences between the drug-bound and -unbound states of the channel that can explain drug resistance.

We also recommend Trading Suppliers and Manufacturers of 2-(α,β)-Hydroxy Rimantadine (cas 127619-49-2). Pls Click Website Link as below: cas 127619-49-2 suppliers

Prev:Heterocyclic rimantadine analogues with antiviral activity
Next:Design, synthesis and molecular modelling of new bulky Fananserin (cas 127625-29-0) derivatives with altered pharmacological profile as potential antidepressants)